The Neuro’s new director, inspired by its past, looks to the future
Dr. Edward Fon’s priorities include bringing new cutting-edge therapies to patients, making the internationally respected institution better known in Quebec Working in Dr. Wilder Penfield’s old office, Dr. Edward Fon says he feels like he’s standing on the shoulders of giants. As The Neuro’s eighth director, he joins a neuroscientific…
Studying how digital technology affects youth? Mind the generational gap!
Dr. Vincent Paquin, a psychiatrist and assistant professor in the McGill Department of Psychiatry, investigates how digital technology shapes young people's mental health....
October 30, 2026
GCHM fall 2026 graduates share how the program fit their needs and advanced their career
On Monday, October 19, sixteen Graduate Certificate in Healthcare Management (GCHM) students walked the stage at convocation. As new alumni, four students reflected...
October 30, 2026
Advancing targeted therapies for brain tumours
For the first time, a targeted therapy specifically designed for a key subtype of tumours is demonstrating meaningful clinical impact. “We finally have...
October 30, 2026
New treatment approach shows promise in reducing prostate cancer spread
Early results from an international study of more than 1,100 patients point to a potential new standard of care Adding darolutamide to standard...
October 30, 2026
Several schizophrenia symptoms linked to a single brain signal
Brain imaging study finds a common thread, may aid in identifying those at high risk of psychosis and provide a future treatment target...
October 30, 2026
Discovery of a potential new vehicle for cancer spread
The discovery of MoVes, a new type of extracellular vesicles containing DNA from migrating cancer cells, could provide valuable insights into how cancer...
October 30, 2026